2-[4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-氧代丁基]苯基]-2,2-二甲基乙酸甲酯

产品供应2-[4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-氧代丁基]苯基]-2,2-二甲基乙酸甲酯

  • 发布日期：2020-06-30
  • 有效期限：30天
湖南复瑞生物医药技术有限责任公司 VIP
C33H39NO4
513.6671
回上一页
联系供应商
在线询盘 打印本页
详细信息
  • ;盐酸非索非那定中间体;+-[4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-氧代丁基]苯基]-2,2-二甲基乙酸甲酯;2-[4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-氧代丁基]苯基]-2,2-二甲基乙酸甲酯;2-[4-[4-[4-羟基二苯基甲基-1-哌啶基]-1-氧代乙基]苯基]-α,α-二甲基乙酸甲酯;4-(4-羟基联苯甲基)哌啶-1-氧代丁基-2,2-二甲基苯乙酸甲酯(F10);2-(4-(4-(4-(羟基二苯甲基)-1-哌啶基)-1-氧代丁基)苯基)-2,2-二甲基乙酸甲酯;非索缩合物;
  • Methyl-4-4(4-hydroxy diphenyl-methyl)-piperidine-1-oxobutyl-2-2-dimethyl phenyl acetic acid
  • ;2-[4-[4-[4-(Hydroxy diphenylmethyl)-1-piperidinyl]-1-oxobutyl]phenyl]-2,2-dimethylacetic acid methyl ester;methyl 2-[4-(4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butanoyl)phenyl]-2-methylpropanoate;Methyl 2-[4-(4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butanoyl)phenyl]-2-methylpropanoate;2-[4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]phenyl]-2,2-dimethylacetic acid methyl ester;2-(4-(4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-1-oxobutyl)phenyl)-2,2-dimethyl acetic acid methylester;Fexofenadine int;Methyl 4-[4-[4-hydroxydiphenylmethyl)-1-piperidinyl]oxobutyl]-2,2-dimethyl benzene acetate;
  • InChI=1/C33H39NO4/c1-32(2,31(36)38-3)26-18-16-25(17-19-26)30(35)15-10-22-34-23-20-29(21-24-34)33(37,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29,37H,10,15,20-24H2,1-3H3
  • 1.132g/cm3
  • 657.185°C at 760 mmHg
  • 351.253°C

免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，化工网对此不承担任何保证责任。我们原则上建议您选择化工网高级会员或VIP会员。